Brand name: Xembify TM
Active ingredients: normal immunoglobulin
What it is used for
Indications for subcutaneous administration (SCIg),Xembify® is indicated as replacement therapy in adult and paediatric patients for:,- Primary immunodeficiency diseases (PID),- Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
How to take it
The way to take this medicine is: Subcutaneous. This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Refrigerate
- Shelf lifetime is 36 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
SCIg
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme